Research & Literature

Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort.

Alchi B, Griffiths M, Sivalingam M, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015; (30(5)):814-21 doi:10.1093/ndt/gfu399.

Atypical anti-glomerular basement membrane disease.

Troxell ML, Houghton DC

Clinical kidney journal 2016; (9(2)):211-21 doi:10.1093/ckj/sfv140.

Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.

McAdoo SP, Tanna A, Hrušková Z, et al.

Kidney international 2017; (92(3)):693-702 doi:10.1016/j.kint.2017.03.014.

Anti-GBM disease after nephrectomy for xanthogranulomatous pyelonephritis in a patient expressing HLA DR15 major histocompatibility antigens: a case report.

O'Hagan E, Mallett T, Convery M, McKeever K

Clinical nephrology. Case studies 2015; (3()):25-30 doi:10.5414/CNCS108594.

Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.

van Daalen EE, Jennette JC, McAdoo SP, et al.

Clinical journal of the American Society of Nephrology : CJASN 2018; (13(1)):63-72 doi:10.2215/CJN.04290417.

Anti-Glomerular Basement Membrane Disease.

Gulati K, McAdoo SP

Rheumatic diseases clinics of North America 2018; (44(4)):651-673 doi:10.1016/j.rdc.2018.06.011.

Antiglomerular Basement Membrane Disease.

McAdoo SP, Pusey CD

Seminars in respiratory and critical care medicine 2018; (39(4)):494-503 doi:10.1055/s-0038-1669413.

Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report.

Thibaud V, Rioux-Leclercq N, Vigneau C, Morice S

BMC nephrology 2019; (20(1)):6 doi:10.1186/s12882-018-1197-6.

A case of aggressive atypical anti-GBM disease complicated by CMV pneumonitis.

Sporinova B, McRae SA, Muruve DA, et al.

BMC nephrology 2019; (20(1)):29 doi:10.1186/s12882-019-1227-z.

Goodpasture's Syndrome with Negative Anti-glomerular Basement Membrane Antibodies.

Vries TB, Boerma S, Doornebal J, et al.

European journal of case reports in internal medicine 2017; (4(8)):000687 doi:10.12890/2017_000687.

Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease.

Nishibata Y, Masuda S, Nakazawa D, et al.

Experimental and molecular pathology 2019; (107()):165-170 doi:10.1016/j.yexmp.2019.02.005.

A relapsing case of pulmonary-renal syndrome after a sequential rise in MPO-ANCA and anti-GBM antibodies.

Hoshino A, Sakairi T, Kayakabe K, et al.

CEN case reports 2019; (8(3)):221-225 doi:10.1007/s13730-019-00397-1.

Anti-glomerular basement membrane disease: A clinicomorphological study of 16 cases.

Vavilapalli S, Madireddy N, Uppin MS, et al.

Indian journal of pathology & microbiology 2020; (63(2)):226-229 doi:10.4103/IJPM.IJPM_712_18.

Atypical Anti-Glomerular Basement Membrane Disease With Diffuse Crescentic Membranoproliferative Glomerulonephritis: Case Report and Review of Literature.

Elshirbeny M, Alkadi MM, Mujeeb I, Fituri O

Qatar medical journal 2020; (2020(1)):16 doi:10.5339/qmj.2020.16.

Long-term outcomes in kidney transplant recipients with end-stage kidney disease due to anti-glomerular basement membrane disease.

Singh T, Kharadjian TB, Astor BC, Panzer SE

Clinical transplantation 2021; (35(2)):e14179 doi:10.1111/ctr.14179.

Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.

Zahir Z, Wani AS, Prasad N, Jain M

Renal failure 2021; (43(1)):79-89 doi:10.1080/0886022X.2020.1854301.

Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease.

Shen CR, Jia XY, Luo W, et al.

Journal of the American Society of Nephrology : JASN 2021; (32(8)):1887-1897 doi:10.1681/ASN.2020101431.

Recurrence and Outcome of Anti-Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation.

Coche S, Sprangers B, Van Laecke S, et al.

Kidney international reports 2021; (6(7)):1888-1894 doi:10.1016/j.ekir.2021.04.011.

Atypical Antiglomerular Basement Membrane Disease in a Pediatric Patient Successfully Treated with Rituximab.

Jen KY, Auron A

Case reports in nephrology 2021; (2021()):2586693 doi:10.1155/2021/2586693.

Accuracy of Anti-GBM Antibodies in Diagnosing Anti-Glomerular Basement Membrane Disease: A Systematic Review and Meta-Analysis.

Shiroshita A, Oda Y, Takenouchi S, et al.

American journal of nephrology 2021; (52(7)):531-538 doi:10.1159/000518362.

Etanercept-Induced Anti-Glomerular Basement Membrane Disease.

Al-Chalabi S, Wu HHL, Chinnadurai R, Ponnusamy A

Case reports in nephrology and dialysis 2021; (11(3)):292-300 doi:10.1159/000518984.

Rapidly progressive glomerulonephritis in children.

Moorani KN, Aziz M, Amanullah F

Pakistan journal of medical sciences 2022; (38(2)):417-425 doi:10.12669/pjms.38.ICON-2022.5774.

Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report.

Matsui K, Kamata W, Mochida Y, et al.

BMC nephrology 2022; (23(1)):136 doi:10.1186/s12882-022-02772-0.

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) for life-threatening isolated pulmonary anti-GBM disease.

Goda S, Gando S, Berg BW

Respiratory medicine case reports 2022; (38()):101680 doi:10.1016/j.rmcr.2022.101680.

Serodiagnosis of Anti-glomerular Basement Membrane Disease Using a Newly Developed Chemiluminescence Immunoassay.

Kühnl A, Hartwig L, Dähnrich C, Schlumberger W

Frontiers in medicine 2022; (9()):915754 doi:10.3389/fmed.2022.915754.

Anti-glomerular Basement Membrane Glomerulonephritis: A Study in Real Life.

Sánchez-Agesta M, Rabasco C, Soler MJ, et al.

Frontiers in medicine 2022; (9()):889185 doi:10.3389/fmed.2022.889185.

Anti-glomerular basement membrane disease: Treatment outcome of cyclophosphamide vs. rituximab induction therapy regimen.

Jaryal A, Vikrant S

Clinical nephrology 2022; (98(6)):280-287 doi:10.5414/CN110851.

Autoimmunity in Anti-Glomerular Basement Membrane Disease: A Review of Mechanisms and Prospects for Immunotherapy.

Kuang H, Liu J, Jia XY, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2023; (81(1)):90-99 doi:10.1053/j.ajkd.2022.07.006.

Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.

Hu X, Shen C, Meng T, et al.

Frontiers in immunology 2022; (13()):991469 doi:10.3389/fimmu.2022.991469.

A case report of atypical anti-glomerular basement membrane disease.

Tamura R, Doi T, Hirashio S, et al.

BMC nephrology 2022; (23(1)):373 doi:10.1186/s12882-022-03007-y.

Risk Stratification to Predict Renal Survival in Anti-Glomerular Basement Membrane Disease.

Floyd L, Bate S, Hadi Kafagi A, et al.

Journal of the American Society of Nephrology : JASN 2023; (34(3)):505-514 doi:10.1681/ASN.2022050581.

Recurrent Nephritis and/or Pulmonary Hemorrhage in Patients with Anti-Glomerular Basement Membrane Disease with and without ANCA Positivity.

Droz N, Katz A, Patel A, et al.

Glomerular diseases 2021; (1(2)):60-67 doi:10.1159/000515388.

Goodpasture syndrome and anti-glomerular basement membrane disease.

Reggiani F, L'Imperio V, Calatroni M, et al.

Clinical and experimental rheumatology 2023; (41(4)):964-974 doi:10.55563/clinexprheumatol/tep3k5.

Atypical Anti-Glomerular Basement Membrane Disease.

Bharati J, Yang Y, Sharma P, Jhaveri KD

Kidney international reports 2023; (8(6)):1151-1161 doi:10.1016/j.ekir.2023.03.010.

Therapeutic plasma exchange for anti-glomerular basement membrane disease with dialysis-dependent kidney failure without diffuse alveolar hemorrhage.

Watanabe H, Yamana H, Okada A, et al.

Journal of nephrology 2023; (36(8)):2317-2325 doi:10.1007/s40620-023-01695-9.

Anti-Glomerular Basement Membrane Disease in a 10-year-old Child: A Case Report.

Anjum MF, Twanabasu S, Shrestha S, et al.

JNMA; journal of the Nepal Medical Association 2023; (61(262)):552-554 doi:10.31729/jnma.8193.

Immunity in the balance: Fatal disseminated adenovirus infection in a patient undergoing plasma exchange and immunosuppressive chemotherapy for anti-glomerular basement membrane disease.

Jacobs JW, Figueroa Villalba CA, Stendahl K, et al.

Journal of clinical apheresis 2023; (38(6)):770-777 doi:10.1002/jca.22088.

Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.

Tang A, Zhao X, Tao T, et al.

Frontiers in immunology 2023; (14()):1229806 doi:10.3389/fimmu.2023.1229806.

The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease.

Yamashita M, Takayasu M, Maruyama H, Hirayama K

Medicina (Kaunas, Lithuania) 2023; (59(11)) doi:10.3390/medicina59112014.

Antiglomerular basement membrane antibody type rapidly progressive glomerulonephritis with seizures: Two cases and literature review.

Han C, Cui X, Tan Z, et al.

Immunity, inflammation and disease 2023; (11(11)):e1074 doi:10.1002/iid3.1074.

Clinical Profile and Renal Survival of Anti-Glomerular Basement Membrane Disease Patients: A Retrospective Case Series from Northern India.

Kumar A, Gupta S, Jarial KDS, et al.

Glomerular diseases 2023; (3(1)):241-247 doi:10.1159/000534498.

Atypical Anti-Glomerular Basement Membrane Nephritis: A Case Series From the French Nephropathology Group.

Chauveau B, Gibier JB, Olagne J, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2024; (83(6)):713-728.e1 doi:10.1053/j.ajkd.2023.11.003.

Anti-Glomerular Basement Membrane Disease: Recent Updates.

Bharati J, Jhaveri KD, Salama AD, Oni L

Advances in kidney disease and health 2024; (31(3)):206-215 doi:10.1053/j.akdh.2024.04.007.

Plasmapheresis, immunosuppressive therapy and anti-GBM disease prognosis: a cohort study of 107 patients.

Liu Y, Wu Y, Wei W, et al.

Renal failure 2024; (46(2)):2400539 doi:10.1080/0886022X.2024.2400539.

Outcome of rituximab treatment in children with non-dialysis-dependent anti-GBM disease.

Klaus R, Kanzelmeyer N, Haffner D, Lange-Sperandio B

Pediatric nephrology (Berlin, Germany) 2025; (40(2)):423-430 doi:10.1007/s00467-024-06512-4.

Management dilemma of anti-GBM disease and p-ANCA-associated vasculitis with necrotizing skin lesions in a pediatric patient.

Chirico V, Silipigni L, Tripodi F, et al.

Pediatric nephrology (Berlin, Germany) 2025; (40(8)):2691-2702 doi:10.1007/s00467-025-06721-5.

Atypical Anti-glomerular Basement Membrane Disease in a 16-Year-Old Male Child: A Case Report.

Singh D, Pugmire B, Sukumaran S

Cureus 2025; (17(2)):e78644 doi:10.7759/cureus.78644.

Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease.

Ivković V, Bajema I, Bruchfeld A, et al.

Kidney international reports 2025; (10(3)):743-752 doi:10.1016/j.ekir.2024.12.026.

A case of anti-glomerular basement membrane disease complicated by severe cytomegalovirus enteritis in a patient who survived after a prolonged ICU stay.

Terunuma Y, Moniwa N, Maeda T, et al.

CEN case reports 2025; (14(4)):653-658 doi:10.1007/s13730-025-00998-z.

Double-filtration plasmapheresis versus therapeutic plasma exchange in the treatment of anti-glomerular basement membrane nephritis: A cohort study.

Liu C, Wei W, Huang Y, et al.

The American journal of the medical sciences 2025; (370(4)):338-346 doi:10.1016/j.amjms.2025.07.007.

Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease.

Kuang H, Wang BN, Jia XY, et al.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025; (41(1)):55-66 doi:10.1093/ndt/gfaf153.

Anti-glomerular basement membrane disease-treatment standard.

McAdoo SP, Pusey CD

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2025; (41(1)):42-54 doi:10.1093/ndt/gfaf190.

Outcomes After Kidney Transplantation in Antiglomerular Basement Membrane Disease.

Traversat P, Dekervel M, Masset C, et al.

Kidney international reports 2025; (10(9)):3150-3163 doi:10.1016/j.ekir.2025.06.021.

Diffuse Alveolar Hemorrhage.

Murray J, O'Brien S, Mitchell PD

Seminars in respiratory and critical care medicine 2026; (47(4)):409-419 doi:10.1055/a-2725-7274.

Kidney Transplantation After Rituximab Treatment for End-Stage Renal Failure With Myeloperoxidase Anti-neutrophil Cytoplasmic and Anti-glomerular Basement Membrane Antibody Positivity: A Case Report.

Sugiura T, Tanaka A, Nishibori N, et al.

Cureus 2025; (17(10)):e94237 doi:10.7759/cureus.94237.

Anti-Glomerular Basement Membrane Disease without Linear IgG Deposits in an Elderly Patient with Metastatic Rectal Cancer: A Case Report.

Chebbo L, Yazbek MA, Kteich Y, et al.

Biomedicine hub 2026; (11(1)):1-6 doi:10.1159/000549688.

Laboratory solution to diagnose and monitor atypical IgG4-mediated anti-GBM disease.

Jacobs JFM, Lambeck AJA, Lammerts RGM, et al.

Clinical chemistry and laboratory medicine 2026; (64(5)):1102-1108 doi:10.1515/cclm-2025-1499.

Late post-transplant recurrence of an anti-myeloperoxydase antibody-associated vasculitis in a former double-positive patient: a case report.

Chenaf-Benabdelmoumene N, Chabannes M, Ducloux D, et al.

Frontiers in immunology 2026; (17()):1723903 doi:10.3389/fimmu.2026.1723903.

[Vasculitides and anti-GBM disease].

Schreiber A, Reimers J

Innere Medizin (Heidelberg, Germany) 2026; (67(5)):515-523 doi:10.1007/s00108-026-02105-5.

Antiglomerular Basement Membrane (Anti-GBM) Glomerulonephritis in the Context of Genitourinary Tuberculosis: A Case Report.

Tan SM, Shanizza QIBA, Balingi D, et al.

Kidney medicine 2026; (8(5)):101338 doi:10.1016/j.xkme.2026.101338.

Anti-GBM pulmonary-renal syndrome: when the laboratory makes the difference.

Frías Ruiz C, Martín Martínez MD

Advances in laboratory medicine 2026; (7(2)):160-162 doi:10.1515/almed-2025-0099.

Rituximab is associated with accelerated dialysis independence in anti-glomerular basement membrane disease: a retrospective cohort analysis of renal survival.

Wang Y, Zhai Z, Wang L, et al.

Frontiers in immunology 2026; (17()):1835889 doi:10.3389/fimmu.2026.1835889.

Multimodal Management of Anti-GBM Disease Complicated by Secondary Complement-Mediated Thrombotic Microangiopathy in a Patient Intolerant to Plasma Exchange: A Case Report.

Yang X, Guo P, Ma L, et al.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2026; doi:10.1002/1744-9987.70172.

Case Report: Elderly anti-GBM antibody disease with diffuse non-hereditary glomerular basement membrane thinning of uncertain etiology.

Yu P, Yang W, Weiwei Z, et al.

Frontiers in medicine 2026; (13()):1883699 doi:10.3389/fmed.2026.1883699.

Anti-glomerular basement membrane disease: A contemporary case series from a large university hospital center.

Catarina Oliveira A, Figueiredo R, Correia R, et al.

Nefrologia 2026; (46(7)):501522 doi:10.1016/j.nefroe.2026.501522.

Concurrent Anti-glomerular Basement Membrane (Anti-GBM) Disease and Immunoglobulin A Nephropathy (IgAN) Presenting With Severe Pulmonary-Renal Syndrome: A Case Report.

Alshuweishi F, Almuhraj M, Benragosh NJ, et al.

Cureus 2026; (18(7)):e113164 doi:10.7759/cureus.113164.